US 9,051,615 B2Granted

Method of detecting and treating tuberous sclerosis complex associated disorders

AssigneeCelldex Therapeutics, Inc.

InventorsLuca Rastelli, Bonnie Gould-Rothberg, Ryan Murphey

Life of this patent

Estimating the term…

Abstract

Disclosed are methods of detecting and treating tuberous sclerosis complex associated disorders. Also disclosed are methods of identifying agents for treating tuberous sclerosis complex associated disorders.

Claims5

Dependent claims

An isolated antibody that immunospecifically binds to an NMB polypeptide encoded by a nucleic acid of SEQ ID NO:26, wherein the NMB polypeptide comprises the amino acid sequence of SEQ ID NO:27.

Dependencies are inferred from the claim text.

Facts

Application: 13/462,300Filed 2 May 2012 · continuation
Priority: 8 Dec 2000
Published: US 2012/0213778 A123 Aug 2012
Granted: 9 Jun 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification27 codes

C12Q 1/6886
For diseases caused by alterations of genetic material: for cancer
A61P 11/00
Drugs for disorders of the respiratory system
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys
A61P 17/00
Drugs for dermatological disorders

Family

Application60/254,268Us provisional application · filed 8 Dec 2000
Application10/016,253Parent of this continuation · filed 10 Dec 2001
Application10/991,173Parent of this continuation · filed 16 Nov 2004
Application12/080,362Parent of this continuation · filed 2 Apr 2008
US 2012/0213778 A1Pre-grant publication · published 23 Aug 2012
US 2003/0124534 A1Published application
US 2005/0181391 A1Published application
US 2008/0292624 A1Published application
US 9,051,615 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results